Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension—Mechanisms and Mitigation
LE Butel-Simoes, TJ Haw, T Williams, S Sritharan… - …, 2023 - Am Heart Assoc
Cardiovascular disease and cancer are 2 of the leading causes of death worldwide.
Although improvements in outcomes have been noted for both disease entities, the success …
Although improvements in outcomes have been noted for both disease entities, the success …
Biomimetic platelet-camouflaged drug-loaded polypyrrole for the precise targeted antithrombotic therapy
Z Zhao, X Li, Y Wang, C Liu, G Ling… - Journal of …, 2023 - Springer
Lower extremity deep venous thrombosis (LEDVT) affects patient's quality of life for a long
time, and even causes pulmonary embolism, which threatens human health. Current …
time, and even causes pulmonary embolism, which threatens human health. Current …
DoxoDB: A Database for the Expression Analysis of Doxorubicin-Induced LncRNA Genes
Cancer and cardiovascular disease are the leading causes of death worldwide. Recent
evidence suggests that these two life-threatening diseases share several features in disease …
evidence suggests that these two life-threatening diseases share several features in disease …
In Vitro Evaluation of Ferutinin Rich-Ferula communis L., ssp. glauca, Root Extract on Doxorubicin-Induced Cardiotoxicity: Antioxidant Properties and Cell Cycle …
R Macrì, I Bava, F Scarano, R Mollace… - International Journal of …, 2023 - mdpi.com
The clinical use of anthracycline Doxorubicin as an antineoplastic drug in cancer therapy is
limited by cardiotoxic effects that can lead to congestive heart failure. Recent studies have …
limited by cardiotoxic effects that can lead to congestive heart failure. Recent studies have …
[HTML][HTML] Social determinants of health in cardio-oncology: multi-level strategies to overcome disparities in care: JACC: CardioOncology state-of-the-art review
Addressing the need for more equitable cardio-oncology care requires attention to existing
disparities in cardio-oncologic disease prevention and outcomes. This is particularly …
disparities in cardio-oncologic disease prevention and outcomes. This is particularly …
[HTML][HTML] Activated fibroblasts in cardiac and cancer fibrosis: An overview of analogies and new potential therapeutic options
Heart disease and cancer are two major causes of morbidity and mortality in the
industrialized countries, and their increasingly recognized connections are shifting the focus …
industrialized countries, and their increasingly recognized connections are shifting the focus …
Malignant Neoplasms Arising in the Cardiac Pacemaker Cavity: A Systematic Review
FCA Moraes, L Dal Moro, FR Pessoa, ESR Passos… - Cancers, 2023 - mdpi.com
Simple Summary Cancer, a complex group of diseases marked by abnormal cell
proliferation and loss of physiological functions. Furthermore, tumors in the cardiac …
proliferation and loss of physiological functions. Furthermore, tumors in the cardiac …
From beats to metabolism: the heart at the core of interorgan metabolic cross talk
R Romero-Becera, AM Santamans, AC Arcones… - …, 2024 - journals.physiology.org
The heart, once considered a mere blood pump, is now recognized as a multifunctional
metabolic and endocrine organ. Its function is tightly regulated by various metabolic …
metabolic and endocrine organ. Its function is tightly regulated by various metabolic …
Cardio-oncoimmunology: cardiac toxicity, cardiovascular hypersensitivity, and Kounis syndrome
NG Kounis, MY Hung, C de Gregorio, V Mplani… - Life, 2024 - mdpi.com
Cancer therapy can result in acute cardiac events, such as coronary artery spasm, acute
myocardial infarction, thromboembolism, myocarditis, bradycardia, tachyarrhythmias, atrio …
myocardial infarction, thromboembolism, myocarditis, bradycardia, tachyarrhythmias, atrio …